TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims for Telix Pharmaceuticals shareholders after the company received an SEC subpoena related to prostate cancer therapeutic candidate disclosures, which caused a 10.44% stock price drop.

Insights
TLX   negative

Received SEC subpoena questioning disclosure practices, experienced significant stock price decline, and facing potential legal action from shareholders